Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Goat anti-Human IgG Antibody (DyLight 549) - Preadsorbed

ELISA, WB, FLISA, FM, DB Polyclonal IgG DyLight 549
Rockland
Catalog No. ABIN6698927
Supplier Product No.: 609-142-123

Quick Overview for Goat anti-Human IgG Antibody (DyLight 549) - Preadsorbed (ABIN6698927)

Target

IgG

Clonality

  • 3106
  • 159
  • 12
  • 1
Polyclonal

Conjugate

  • 549
  • 381
  • 371
  • 291
  • 226
  • 211
  • 189
  • 107
  • 99
  • 72
  • 57
  • 55
  • 54
  • 50
  • 48
  • 47
  • 44
  • 43
  • 40
  • 39
  • 38
  • 37
  • 36
  • 35
  • 31
  • 29
  • 29
  • 29
  • 29
  • 29
  • 29
  • 27
  • 27
  • 26
  • 26
  • 25
  • 24
  • 23
  • 23
  • 23
  • 23
  • 22
  • 22
  • 22
  • 22
  • 21
  • 19
  • 17
  • 17
  • 17
  • 15
DyLight 549

Application

  • 1721
  • 1703
  • 1690
  • 1623
  • 920
  • 873
  • 803
  • 403
  • 347
  • 232
  • 232
  • 103
  • 86
  • 61
  • 50
  • 31
  • 24
  • 19
  • 18
  • 18
  • 16
  • 16
  • 12
  • 9
  • 8
  • 8
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Western Blotting (WB), FLISA, Fluorescence Microscopy (FM), Dot Blot (DB)

Isotype

IgG
  • Reactivity

    • 628
    • 576
    • 560
    • 396
    • 360
    • 232
    • 189
    • 150
    • 134
    • 125
    • 111
    • 88
    • 86
    • 85
    • 82
    • 62
    • 47
    • 28
    • 27
    • 16
    • 15
    • 10
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human

    Host

    • 1535
    • 1394
    • 548
    • 209
    • 97
    • 84
    • 38
    • 25
    • 21
    • 20
    • 16
    • 11
    • 10
    Goat

    Supplier Product No.

    609-142-123

    Supplier

    Rockland

    Purpose

    Human IgG (H&L) Antibody DyLight™ 549 Conjugated Pre-Adsorbed

    Cross-Reactivity (Details)

    Minimal crossreactivity against Bv Ch Gt GP Ham Hs Ms Rb Rt & Sh Serum Proteins

    Characteristics

    Goat Anti Human IgG DyLight 549™ Conjugated Antibody, Goat Anti-Human IgG Antibody DyLight 549™ conjugation,Anti-Human IgG (H&L) DyLight 549 generated in goat detects human Immunoglobulin G (IgG), both heavy and light chains of the antibody molecule are present.

    Purification

    Preadsorption: Pre-Adsorbed

    Immunogen

    Human IgG whole molecule

    Labeling Ratio

    4.9
  • Application Notes

    FLISA_Dilution: >1:20,000

    IF_Microscopy_Dilution: >1:5,000

    Western_Blot_Dilution: >1:10,000

    Other: User Optimized

    Comment

    Anti-Human IgG (H&L) DyLight 549 has been tested by ELISA and dot blot and is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms. The emission spectra for this DyLight™ conjugate match the principle output wavelengths of most common fluorescence instrumentation.
    Suggested Applications: WB

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitution Volume: 100 μL

    Reconstitution Buffer: Restore with deionized water (or equivalent)

    Concentration

    1.0 mg/mL

    Buffer

    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 10 mg/mL Bovine Serum Albumin (BSA) - Immunoglobulin and Protease free, 0.01 % (w/v) Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store conjugated secondary antibody at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing.  Centrifuge product if not completely clear after standing at room temperature. Conjugated Secondary Antibody is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Expiry Date

    12 months
  • Stork, Ellenberger, Ruprecht, Reindl, Beißbarth, Friede, Kümpfel, Gerdes, Gloth, Liman, Paul, Brück, Metz: "Antibody signatures in patients with histopathologically defined multiple sclerosis patterns." in: Acta neuropathologica, Vol. 139, Issue 3, pp. 547-564, (2021) (PubMed).

    Wallménius, Påhlson, Nilsson: "Retrospective serological study of Rickettsia spp. and Borrelia spp. antibodies in patients with peripheral facial nerve palsy." in: Infection ecology & epidemiology, Vol. 11, Issue 1, pp. 1987058, (2021) (PubMed).

    Lindblom, Wallménius, Sjöwall, Fryland, Wilhelmsson, Lindgren, Forsberg, Nilsson: "Prevalence of Rickettsia spp. in Ticks and Serological and Clinical Outcomes in Tick-Bitten Individuals in Sweden and on the Åland Islands." in: PLoS ONE, Vol. 11, Issue 11, pp. e0166653, (2017) (PubMed).

    Metz, Beißbarth, Ellenberger, Pache, Stork, Ringelstein, Aktas, Jarius, Wildemann, Dihazi, Friede, Brück, Ruprecht, Paul: "Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis." in: Neurology(R) neuroimmunology & neuroinflammation, Vol. 3, Issue 2, pp. e204, (2016) (PubMed).

  • Target

    IgG

    Target Type

    Antibody

    Background

    It is a protein complex composed of four peptide chains - two identical heavy chains and two identical light chains arranged in a Y-shape typical of antibody monomers. Each IgG has two antigen binding sites. Representing approximately 75 % of serum immunoglobulins in humans, IgG is the most abundant antibody isotype found in the circulation. IgG molecules are synthesized and secreted by plasma B cells. Secondary Antibodies are available in a variety of formats and conjugate types. When choosing a secondary antibody product, consideration must be given to species and immunoglobulin specificity, conjugate type, fragment and chain specificity, level of cross-reactivity, and host-species source and fragment composition.
You are here:
Chat with us!